ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Forms Lung Cancer Program for Research On Early Detection, Treatment.

June 23, 2006

Cervarix Vaccine Approved To Prevent Cervical Cancer

October 30, 2009

House Committee Investigates ESA Safety, Urges Amgen, J&J, To Stop Promotions.

March 23, 2007

Thompson Tours Brown’s Brain Science Center.

March 16, 2001

Hospice Assn. Meeting Planned for April

January 24, 1986

Cancer Control Survey “a Flop,” Advisory committee Members Say

October 11, 1974